FDA approves first gene therapy for genetic hearing loss
Berkeley Lovelace Jr.NBC News
The FDA approved a gene-therapy drug from Regeneron to treat genetic hearing loss.
The FDA approved a gene-therapy drug from Regeneron to treat genetic hearing loss.
Reported by NBC NewsRead original
Coverage from 1 source
Coverage by lean
- Unknown1
Comments
Loading comments…
Sign in to join the discussion.
Sign in with SpryLogin